The inflammatory cascade can downregulate glucose transporters and insulin-related molecules (such as GLUT4, cyclin A, cyclin E, and IRS-1), leading to elevated blood glucose and insulin resistance in patients with T2DM [34]. This evidence concerns the gene SLC2A4 and type 2 diabetes mellitus.